GCT is taking part in the CTAD Alzheimer Congress

GCT President, Dr.
Jeffrey Apter is participating at the 13^th Clinical Trials on Alzheimer’s
Disease Congress (CTAD) which is held from 4^th to 7^th of
November.

The congress
brings worldwide leaders in the treatment of Alzheimer’s disease together, and
is a perfect platform to share their expertise in the research
of Alzheimer’s disease. Dr. Apter is KOL in psychiatry and has over 30
years of experience in clinical research focusing on Alzheimer’s disease.

Reach out to us at
bd@gctrials.com if you would like to set up a meeting.